Purchase Order 75N91024P00726

<p>This is a firm fixed-price purchase order contract awarded to Ultivue Inc. by the National Cancer Institute, a civilian federal agency, for software. The contract has a ceiling value of $15,000.00 and an ultimate completion date of September 14, 2025. The contract was awarded on September 15, 2024 and does not have a set-aside designation. No further details about the software requirements or a larger contracting vehicle are provided.</p>

<p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Firm Fixed Price purchase order contract to Ultivue Inc., a for-profit organization, for the provision of Biological Kits. The contract, which does not have a set-aside designation, is valued at $24,940.00 and has a completion date of June 1, 2024. The place of performance is Cambridge, MA 02138, USA.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...

This is a $299,717 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Ultivue Inc., a for-profit organization based in Cambridge, Massachusetts. The contract was awarded under the SBIR (Small Business Innovation Research) program and is designated as a Total Small Business set-aside. The contract is for the &quot;PROXIMITY DNA EXCHANGE IMAGING&quot; research project,...

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at fourteen thousand four hundred ninety dollars to Certara USA Inc. for software licenses. Certara will provide the licenses to the NIH NCI in support of its mission to conduct and coordinate research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer,...

<p>The National Cancer Institute awarded a $25,000.00 firm fixed price purchase order contract to Metricwire Inc. for a software license. The contract has an ultimate completion date of June 30, 2025 and was awarded on July 1, 2024. The place of performance is located in Ottawa, Ontario, Canada. This contract award does not have a set-aside designation.</p>

<p>The National Cancer Institute awarded a $21,000.00 firm fixed price purchase order to Omapix Inc. for data analysis services to support spatial transcriptomics/molecular cartography data analysis for the Murgai Lab. The contract has an ultimate completion date of August 31, 2024 and does not have a set-aside designation. This award appears to be a discrete purchase of data analysis services and is not associated with a larger contract vehicle.</p>

The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Revvity Signals Software, Inc. Informatics Division for SOFTWARE. The prime contractor will deliver the requested software products and services over a one-year period of performance from August 1, 2023 through July 31, 2024 under a firm fixed price contract. Revvity Signals Software, Inc. Informatics Division is a subsidiary of Revvity Inc. Medical Imaging, LLC...